Patents by Inventor Christopher J. Paszty

Christopher J. Paszty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10562964
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Grant
    Filed: February 15, 2016
    Date of Patent: February 18, 2020
    Assignee: AMGEN INC.
    Inventor: Christopher J. Paszty
  • Publication number: 20200048338
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Application
    Filed: October 23, 2019
    Publication date: February 13, 2020
    Inventor: Christopher J. Paszty
  • Publication number: 20160168241
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Application
    Filed: February 15, 2016
    Publication date: June 16, 2016
    Inventor: Christopher J. Paszty
  • Patent number: 9353174
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Grant
    Filed: February 20, 2014
    Date of Patent: May 31, 2016
    Assignee: AMGEN INC.
    Inventors: Christopher J. Paszty, Hsieng Sen Lu
  • Patent number: 9296812
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: March 29, 2016
    Assignee: AMGEN INC.
    Inventor: Christopher J. Paszty
  • Publication number: 20140248666
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Application
    Filed: February 20, 2014
    Publication date: September 4, 2014
    Applicant: Amgen Inc.
    Inventors: Christopher J. Paszty, Hsieng Sen Lu
  • Patent number: 8715663
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Grant
    Filed: April 28, 2011
    Date of Patent: May 6, 2014
    Assignee: Amgen Inc.
    Inventors: Christopher J. Paszty, Hsieng Sen Lu
  • Patent number: 8383801
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Grant
    Filed: November 19, 2010
    Date of Patent: February 26, 2013
    Assignee: Amgen Inc.
    Inventor: Christopher J. Paszty
  • Publication number: 20110305702
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Application
    Filed: April 28, 2011
    Publication date: December 15, 2011
    Applicants: AMGEN INC., UCB PHARMA S.A.
    Inventors: HSIENG S. LU, CHRISTOPHER J. PASZTY, MARTYN KIM ROBINSON, ALISTAIR J. HENRY, KELLY SUE WARMINGTON, JOHN LATHAM, ALASTAIR LAWSON, DAVID G. WINKLER, AARON GEORGE WINTERS
  • Publication number: 20110097342
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Application
    Filed: November 19, 2010
    Publication date: April 28, 2011
    Applicants: AMGEN INC., UCB PHARMA S.A.
    Inventors: Christopher J. Paszty, Martyn K. Robinson, Kevin Graham, Alistair J. Henry, Kelly S. Warmington, John Latham, Hsieng S. Lu, Alastair Lawson, Andy Popplewell, Wenyan Shen, David G. Winkler, Aaron G. Winters
  • Patent number: 7872106
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Grant
    Filed: November 24, 2008
    Date of Patent: January 18, 2011
    Assignees: Amgen Inc., UCB Pharma S.A.
    Inventors: Christopher J. Paszty, Martyn K. Robinson, Kevin Graham, Alistair J. Henry, Kelly S. Warmington, John Latham, Hsieng S. Lu, Alastair Lawson, Andy Popplewell, Wenyan Shen, David G. Winkler, Aaron G. Winters
  • Publication number: 20100036091
    Abstract: Compositions and methods relating to sclerostin binding agents, such as antibodies and polypeptides capable of binding to sclerostin, are provided.
    Type: Application
    Filed: November 9, 2007
    Publication date: February 11, 2010
    Applicants: AMGEN INC., UCB PHARMA S.A.
    Inventors: Martyn Kim Robinson, Christopher J. Paszty, Alastair James Henry, Alistair Lawson, Andy Popplewell
  • Publication number: 20080161240
    Abstract: The present invention relates to novel Cloaked-2 polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing Cloaked-2 polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with Cloaked-2 polypeptides.
    Type: Application
    Filed: September 7, 2007
    Publication date: July 3, 2008
    Applicant: AMGEN INC.
    Inventors: Christopher J. Paszty, Yongming Gao
  • Publication number: 20040146888
    Abstract: The present invention relates to novel Cloaked-2 polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing Cloaked-2 polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with Cloaked-2 polypeptides.
    Type: Application
    Filed: October 6, 2003
    Publication date: July 29, 2004
    Inventors: Christopher J. Paszty, Yongming Gao
  • Publication number: 20020123618
    Abstract: The present invention provides Leucine-Rich Repeat-Containing G-Protein Coupled Receptor-8 (LGR8) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing LGR8 polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with LGR8 polypeptides.
    Type: Application
    Filed: August 10, 2001
    Publication date: September 5, 2002
    Applicant: Amgen, Inc.
    Inventors: Christopher J. Paszty, Jianhua Gong, Betsy Daugherty, Norma Rogers
  • Publication number: 20020106650
    Abstract: The present invention relates to novel Cloaked-2 polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing Cloaked-2 polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with Cloaked-2 polypeptides.
    Type: Application
    Filed: May 29, 2001
    Publication date: August 8, 2002
    Inventors: Christopher J. Paszty, Yongming Gao